Wall Street giant Morgan Stanley promoted 173 of its employees to managing director roles this year, marking a 12% increase ...

Morgan Stanley (MS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Morgan Stanley is a buy on weakness with strong dividend growth and projected revenue growth in Q4 2024 and early 2025. Click for our MS earnings preview.

JP Morgan analyst Kian Abouhossein maintained a Neutral rating and boosted the price target from $100 to $104 on Dec. 6, 2024 ...

Morgan Stanley expects improving freight conditions and upcoming emissions regulations to boost global truck manufacturers in 2025, with Daimler (OTC:MBGAF) Truck Holding AG (F:DTGGe) and Volvo ...

The performance of Morgan Stanley’s MS trading business (constituting a significant portion of its top line) is expected to ...

Investing.com - Experian's (LON:EXPN) outlook for margin expansion is "robust" and underpins the potential for sustained ...

Vir Biotechnology (VIR) stock was upgraded by Morgan Stanley after the company posted trial data for two antitumor agents ...

Morgan Stanley Investment Management (MSIM) announced today that the 1GT private climate equity strategy (1GT) participated in a ?115 million fundraise for XOCEAN (company), a leading provider of ...

Global equity issuance rose 20% last year, but stock market launches have so far lagged that increase, remaining far below ...

Andrew Forrest has taken a ‘bring it on’ stance in response to ExxonMobil’s defamation lawsuit, which it has filed against ...

British equities slipped on Friday, with financial sectors such as insurance and lenders leading losses ahead of the U.S.